3,688
edits
No edit summary |
No edit summary |
||
Line 30: | Line 30: | ||
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640. | Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., ... & Okechukwu, K. (2023). Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics, 151(2), e2022060640. | ||
[https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery American Society of Anesthesiologists. Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests] | [https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/patients-taking-popular-medications-for-diabetes-and-weight-loss-should-stop-before-elective-surgery American Society of Anesthesiologists. Patients Taking Popular Medications for Diabetes and Weight Loss Should Stop Before Elective Surgery, ASA Suggests] | ||
Line 38: | Line 36: | ||
[https://www.nejm.org/doi/full/10.1056/NEJMoa2208601 Once-Weekly Semaglutide in Adolescents with Obesity] | [https://www.nejm.org/doi/full/10.1056/NEJMoa2208601 Once-Weekly Semaglutide in Adolescents with Obesity] | ||
[https://pubmed.ncbi.nlm.nih.gov/33567185/ STEP 1 Study Group. Once-Weekly Semaglutide in Adults with Overweight or Obesity] | |||
[https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension] | [https://pubmed.ncbi.nlm.nih.gov/35441470/ STEP 1 Study Group. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension] |